What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 15.3% in the pre-market session after peer ...

Humana (NYSE:HUM) has failed in an administrative appeal submitted to the Centers for Medicare and Medicaid Services in ...

The decision, which Humana disclosed in a Tuesday filing with the court overseeing its lawsuit against the HHS, will be ...

According to Humana, CMS miscalculated its scores, which spelled bad news for the company's finances because higher star ...

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...

With U.S. stock markets set to open in two hours, Regions Financial Corp. (RF) was up 12.5% in pre-market trading, and Eli Lilly & Co. (LLY) was up 11.1%.

UnitedHealthcare's parent company experienced a 20% drop in its stock value on Thursday, a drop attributed to higher-than-expected medical costs.

Morgan Stanley raised the firm’s price target on Humana (HUM) to $290 from $285 and keeps an Equal Weight rating on the shares. While policy ...

UnitedHealth (UNH) is America's largest private health insurer. That's its biggest problem. The parent company, UnitedHealth ...

The stock's fall snapped a five-day winning streak.

Health insurance stocks extended Monday’s gains into Tuesday after Medicare regulators finalized stronger-than-expected 2026 ...

The Centers for Medicare & Medicaid Services projects a 5.06% increase in payments, driven by new data on fee-for-service ...